Cantor Fitzgerald initiated coverage of Aardvark Therapeutics (AARD) with an Overweight rating and $50 price target Aardvark is developing ARD-101, a gut-restricted drug in Phase 3 for Prader ...

RBC Capital analyst Brian Abrahams initiated coverage of Aardvark Therapeutics (AARD) with an Outperform rating and $21 price target Aardvark Therapeutics has a shot at establishing a key role for ...

Get Instant Summarized Text (Gist) Possible aardvark trace fossils, including tracks and burrows, have been identified in Pleistocene aeolianites on South Africa's Cape coast. These findings are ...

Executives from Bechtel, Fluor, Turner Construction, North America’s Building Trades Unions, Kiewit, Clark Construction and Skanska discuss strategies to prevent industry suicides in a recent ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

In this article, we are going to take a look at where Aardvark Therapeutics, Inc. (NASDAQ:AARD) stands against other stocks with at least $10 million in insider spending recently. Since Donald ...

Meghan Markle recently unveiled her rebranded lifestyle brand, As Ever, and its new logo is packed with subtle nods to her family and personal history. The design features a palm tree encased by ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

At least two people died and seven were injured after a collapse at a highway construction site in the South Korean city of Anseong, fire authorities said. The steel structures supporting the ...

The landing page revealed the As Ever logo, which PEOPLE understands is a tribute to Prince Harry. The logo incorporates a palm tree as a nod to the Duke and Duchess’s home in California ...

Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight ...